New antiviral agent. Hepatitis B therapy with slight resistance risk
MMWFortschrittederMedizin 145(51-52): 40
2003
ISSN/ISBN: 1438-3276 PMID: 14974332 Document Number: 565287
Document emailed within 1 workday
Related Documents
Fedorchenko, S.V. 1994: Can chronic hepatitis B patients overcome resistance to antiviral therapy due to production of antibodies to recombinant alpha-2-interferon? Voprosy Virusologii 39(5): 218-220Marcellin, P.; Lada, O. 2006: Managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B Gastroenterologie Clinique et Biologique 30(10 Part 2): 3s5-3s8
Lennerstrand, J.; Bondeson, K.år.; Bergqvist, A.; Blomberg, J.; Oberg, B. 2009: New antiviral agents against hepatitis C in clinical trials. Hope for a cure--but resistance problems must be overcomed Lakartidningen 106(48): 3254-3256; 3258, 3260
Sloan, R.D.; Ijaz, S.; Moore, P.L.; Harrison, T.J.; Teo, C.-G.; Tedder, R.S. 2008: Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant Antiviral Therapy 13(3): 439-447
Schalm, S.W.; Brouwer, J.T. 1997: Antiviral therapy of hepatitis C Scandinavian Journal of Gastroenterology. Suppl 223: 46-49
Geller, L.I. 1990: Antiviral preparations in the therapy of chronic viral hepatitis Terapevticheskii Arkhiv 62(11): 15-19
Broniarek, E. 1994: Immunologic processes in human placenta and their role in antiviral resistance. I. Virus infections of the uterus. Nonspecific antiviral immunity Postepy Higieny i Medycyny Doswiadczalnej 48(3): 227-241
Ono, S.K.; da Silva, L.C.; Carrilho, F.J.; da Fonseca, L.E.; Mendes, L.C.; Madruga, C.L.; Farias, A.d.Q.; Laudanna, A.A. 1996: Clearance of hepatitis C viral RNA in cirrhotic patients with antiviral therapy Revista do Hospital das Clinicas 51(5): 180-183
Lopukhova, N.L. 2007: Antiviral therapy of patients with chronic hepatitis C with normal level of aminotransferases Eksperimental'naia i Klinicheskaia Gastroenterologiia 4: 146-152
Zhdanov, K.V.; Gusev, D.A.; Kozlov, K.V.; Shishkin, M.K.; Sukachev, V.S.; Shakhmanov, D.M.; Zhabrov, S.S. 2015: Effectiveness and safety of antiviral therapy of military personnel suffering from chronic hepatitis C Voenno-Meditsinskii Zhurnal 336(4): 44-49
De Almeida, A.J.é; Campos-de-Magalhães, M.; Brandão-Mello, C.E.; de Oliveira, R.V.; do Espirito-Santo, M.ár.P.; Yoshida, C.F.T.; Lampe, E. 2009: Detection of hepatitis C virus in platelets: evaluating its relationship to antiviral therapy outcome Hepato-Gastroenterology 56(90): 429-436
Selivestrova, T.R.; Trufanova, I.M.; Morozov, S.V.; Isakov, V.A. 2011: Indicators of body composition as prognostic factors of efficiency of antiviral therapy for chronic hepatitis C Eksperimental'naia i Klinicheskaia Gastroenterologiia 1: 54-58
de Artaza, T.; Sánchez, J.J.; González, C.; Pérez-Grueso, M.J.; Repiso, A.; Gómez, R.; Potenciano, J.L.M. 2004: Peripheral facial paralysis during interferon treatment in hepatitis C: recovery without antiviral therapy withdrawal Gastroenterologia y Hepatologia 27(7): 434-435
Muñoz, A.E. 2007: New strategies for a better use of peginterferon and ribavirin and new drugs with specifically-targeted antiviral therapy for chronic hepatitis C Acta Gastroenterologica Latinoamericana 37(2): 126-133
Baranova, I.P.; Zykova, O.A.; Krasnova, L.I.; Romantsov, M.G.; Nikol'skaia, M.V.; Aftaeva, L.N. 2013: Efficiency of remaxol in preventing unwanted side effects of the antiviral therapy in patients with chronic hepatitis C Eksperimental'naia i Klinicheskaia Farmakologiia 76(11): 44-46
Xu, D.-Z.; Xie, Y.; Li, Z.-Q. 2005: Clearance of HCV RNA in peripheral blood mononuclear cell as a predictor of response to antiviral therapy in patients with chronic hepatitis C Hepatobiliary and Pancreatic Diseases International: Hbpd Int 4(4): 550-553
Dong, Y.; Zhang, H.-f.; Chen, H.; Li, J.; Yang, X.-j.; Zhu, S.-s.; Cheng, Y. 2008: Level of the cytokine secreted by periferal blood mononuclear cells in patients with chronic hepatitis C before antiviral therapy Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 22(5): 364-366
Ow, M.M.G.; de Zoysa, J.R.; Gane, E.J. 2014: The impact of oral antiviral therapy on long-term survival of hepatitis B surface antigen-positive patients on haemodialysis New Zealand Medical Journal 127(1396): 34-42
Gwak, G-Youn.; Kim, T.Hun.; Yu, S.Jong.; Yoon, J-Hwan.; Yong, J.Jung.; Park, S.Cheol.; Lee, H-Suk. 2007: Lack of association between serum leptin levels and hepatic steatosis, fibrosis or response to antiviral therapy in Korean chronic hepatitis C patients Hepato-Gastroenterology 54(75): 844-848
Watanabe, H.; Ueno, Y. 2015: Seroclearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in hepatitis B virus patients during nucleoside/nucleotide analog therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 459-465